[1]
B. Zamani, S. R., and E. A., “Protective effect of carvedilol against anthracycline-induced cardiomyopathy on patients with breast cancer and lymphoma”, Int J Adv Med, vol. 5, no. 1, pp. 16–20, Jan. 2018.